Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ENTA

Enanta Pharmaceuticals (ENTA)

Enanta Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENTA
DateTimeSourceHeadlineSymbolCompany
05/08/20243:37PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ENTAEnanta Pharmaceuticals Inc
05/08/20243:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENTAEnanta Pharmaceuticals Inc
05/07/20246:00AMBusiness WireEnanta Pharmaceuticals to Participate at the JMP Securities Life Sciences ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
05/06/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENTAEnanta Pharmaceuticals Inc
05/06/20243:01PMBusiness WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ETNASDAQ:ENTAEnanta Pharmaceuticals Inc
04/30/20246:10AMBusiness WireEnanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
04/30/20246:00AMBusiness WireEnanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal OfficerNASDAQ:ENTAEnanta Pharmaceuticals Inc
04/29/20246:00AMBusiness WireEnanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024NASDAQ:ENTAEnanta Pharmaceuticals Inc
04/17/20246:00AMBusiness WireEnanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024NASDAQ:ENTAEnanta Pharmaceuticals Inc
03/08/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
03/08/20244:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
03/08/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
03/08/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
03/08/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
03/08/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
03/06/20246:00AMBusiness WireEnanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/27/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/27/202412:11PMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/14/20247:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/14/20247:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/14/20247:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/14/20247:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/14/20247:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/14/20247:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/14/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/14/20241:26PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ENTAEnanta Pharmaceuticals Inc
02/08/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/08/20243:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENTAEnanta Pharmaceuticals Inc
02/07/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENTAEnanta Pharmaceuticals Inc
02/07/20243:01PMBusiness WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ETNASDAQ:ENTAEnanta Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ENTA